India

Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to...

Web article – Last updated 11 September 2012
msfaccess.org/content/infographics-big-pharmas-continued-attack-india-pharmacy-developing-world

Case could negatively impact India’s role as ‘pharmacy of the developing world’ New Delhi/Geneva 11 September 2012 – Swiss pharmaceutical company Novartis heads to the Indian...

Press Release – Last updated 11 September 2012
msfaccess.org/about-us/media-room/press-releases/novartis%E2%80%99-six-year-legal-challenge-against-india%E2%80%99s-pro-health

Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...

Statements, Speeches, Letters – Last updated 21 August 2012
msfaccess.org/content/bayernatco-compulsory-licence-appeal-%E2%80%93-hearings-postponed

Multimedia – Last updated 10 September 2012
msfaccess.org/content/msf-protests-against-novartis-case-india

Multimedia – Last updated 15 August 2012
msfaccess.org/content/shantis-story-struggling-find-mdr-tb-treatment-india

Many patients with drug-resistant TB that arrive at MSF’s clinic in Mumbai have received incorrect or inadequate treatment in the private sector. Although this form of TB is curable if treated...

Web article – Last updated 15 August 2012
msfaccess.org/content/struggling-find-mdr-tb-treatment-india

Washington, DC, 25 July 2012 —Middle-income countries are increasingly taking measures to overcome the patents that price drugs out of reach, according to a new report released today from...

Press Release – Last updated 26 July 2012
msfaccess.org/about-us/media-room/press-releases/middle-income-countries-flex-muscles-overcome-patents-face

Multimedia – Last updated 24 July 2012
msfaccess.org/content/my-life-hiv-veena

Médecins Sans Frontières (MSF) has learnt this morning that final arguments in the Indian Supreme Court case of Novartis vs. Government of India has been re-scheduled for 11 September...

Web article – Last updated 22 August 2012
msfaccess.org/content/update-intellectual-property-battles-continue-india-novartis-trial-further-delayed

Objectives: Bihar, the poorest state in India, concentrates most of the visceral leishmaniasis (VL) cases in the country. A large proportion of the poor rural communities where VL is endemic are marginalized...

In Medical Journals / Research Articles – Last updated 04 May 2012
msfaccess.org/content/low-castes-have-poor-access-visceral-leishmaniasis-treatment-bihar-india